CARsgen Therapeutics (CARsgen), a global leader in developing chimeric antigen receptor T-cell (CAR-T cell) therapies for solid tumors announced its first-in-class anti-Claudin18.2-CAR-T cell therapy...
Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes, now have access to...
Teva Pharmaceutical Industries Ltd announced the launch of generic Glumetza®1 (metformin hydrochloride extended-release tablets), 500 mg and 1000 mg, in the U.S. Metformin hydrochloride...
Sun Pharma announced that one of its wholly owned subsidiaries has received approval from USFDA for its New Drug Application (NDA) related to BromSite™...